1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (212) 410–7194
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
Acute toxicity and preliminary response
Article first published online: 17 JUN 2009
DOI: 10.1002/cncr.24412
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Kao, J., Packer, S., Vu, H. L., Schwartz, M. E., Sung, M. W., Stock, R. G., Lo, Y.-C., Huang, D., Chen, S.-H. and Cesaretti, J. A. (2009), Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases. Cancer, 115: 3571–3580. doi: 10.1002/cncr.24412
Publication History
- Issue published online: 20 JUL 2009
- Article first published online: 17 JUN 2009
- Manuscript Accepted: 13 JAN 2009
- Manuscript Revised: 22 DEC 2008
- Manuscript Received: 29 OCT 2008
Funded by
- Mount Sinai School of Medicine
- Department of Radiation Oncology and Pfizer
Corrected by:
Vol. 117, Issue 12, 2826, Article first published online: 14 DEC 2010
References
- 1, . Cancer undefeated. N Engl J Med. 1997; 336: 1569-1574.
- 2, , . Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia and London: Lippincott Williams & Wilkins; 2005.
- 3, , , et al. Liver resection for colorectal metastases. J Clin Oncol. 1997; 15: 938-946.
- 4, , , et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg. 1999; 229: 602-610.
- 5
- 6, , , et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006; 355: 2733-2743.
- 7, , , et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350: 2335-2342.
- 8, , , et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med. 2007; 357: 2040-2048.
- 9, , , et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007; 357: 2666-2676.
- 10, , , et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004; 351: 1513-1520.
- 11, , , et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006; 355: 2542-2550.
- 12, , et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005; 353: 123-132.
- 13, , , et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004; 25: 1677-1683.
- 14, , . Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA. 2002; 99: 13085-13089.
- 15, . The hallmarks of cancer. Cell. 2000; 100: 57-70.
- 16
- 17, , , et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature. 1998; 394: 287-291.
- 18, , , et al. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res. 2003; 63: 4009-4016.
- 19, . Metastatic and Recurrent Tumors. In: MundtAJ, RoeskeJC, eds. Intensity Modulated Radiation Therapy: A Clinical Perspective. Hamilton: BC Decker; 2005: 593-598.
- 20, , , , . Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007; 25: 947-952.
- 21, , , et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer. 2008; 112: 650-658.Direct Link:
- 22, , . Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008; 3: 36.
- 23, , , et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007; 356: 115-124.
- 24, , , et al. An initial report of a radiation dose-escalation trial in patients with 1 to 5 sites of metastatic disease. Clin Cancer Res. 2008; 14: 5255-529.
- 25, , . Extracranial stereotactic radiation delivery. Semin Radiat Oncol. 2005; 15: 202-207.
- 26, , , et al. CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery. 2004; 55: 89-98;discussion 98-9.
- 27, , , et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001; 19: 164-170.
- 28, , , et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006; 368: 1329-1338.
- 29, , , et al. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2008; 26: 1810-1816.
- 30, , , et al. Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol. 2006; 24: 25-35.
- 31, , , et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol. 2008; 26: 127-132.